Search details
1.
NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients.
Eur J Immunol
; 42(11): 3038-48, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-22930439
2.
EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone.
Vaccine
; 26(25): 3162-74, 2008 Jun 13.
Article
in English
| MEDLINE | ID: mdl-18502003
3.
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.
J Exp Med
; 205(1): 63-77, 2008 Jan 21.
Article
in English
| MEDLINE | ID: mdl-18195071
Results
1 -
3
de 3
1
Next >
>>